Syed Anjum

Oct 24, 2024 | ccforum.biomedcentral.com | Sinclair De Frías |Syed Anjum |Ricardo Diaz |Ricardo Díaz |Moreno Franco

During the study period, 8098 patients were screened. Of these patients, 346 received inhaled nitric oxide (iNO). We subdivided our patients into two cohorts: those who were spontaneously breathing with (n = 153) or without iNO (n = 1726) use and those who were intubated then were started (n = 193) or were not started (n = 695) on iNO. This cohort included 1879 spontaneously breathing patients. Among these, 153 received iNO while on HFNC/ NIV, and 1726 did not.